KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Buildings (2016 - 2024)

Historic Buildings for Merck (MRK) over the last 16 years, with Q4 2024 value amounting to $16.4 billion.

  • Merck's Buildings rose 931.44% to $16.4 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $16.4 billion, marking a year-over-year increase of 931.44%. This contributed to the annual value of $16.4 billion for FY2024, which is 931.44% up from last year.
  • Per Merck's latest filing, its Buildings stood at $16.4 billion for Q4 2024, which was up 931.44% from $15.0 billion recorded in Q4 2023.
  • Over the past 5 years, Merck's Buildings peaked at $16.4 billion during Q4 2024, and registered a low of $12.0 billion during Q4 2020.
  • In the last 5 years, Merck's Buildings had a median value of $13.2 billion in 2022 and averaged $13.8 billion.
  • As far as peak fluctuations go, Merck's Buildings rose by 7.51% in 2020, and later soared by 1367.16% in 2023.
  • Quarter analysis of 5 years shows Merck's Buildings stood at $12.0 billion in 2020, then grew by 4.43% to $12.5 billion in 2021, then increased by 5.08% to $13.2 billion in 2022, then increased by 13.67% to $15.0 billion in 2023, then grew by 9.31% to $16.4 billion in 2024.
  • Its Buildings was $16.4 billion in Q4 2024, compared to $15.0 billion in Q4 2023 and $13.2 billion in Q4 2022.